Found
Editorial reviewA coaching-first program with aggressive, identical pricing on both molecules.
Visit FoundHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
A coaching-first program with aggressive, identical pricing on both molecules.
Visit FoundThe widest formulary on the board — both molecules, brand-name and oral routes — nationwide and LegitScript-verified.
Visit VaylenToo close to call. Found and Vaylen land on the same Verdict Score of 88/100, so this one comes down to your priorities rather than our scoreboard. Weigh the factor-by-factor breakdown and pricing below — people who want behavior-change coaching bundled with medication.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | Found | Vaylen |
|---|---|---|
| Verdict Score | 88/100 | 88/100 |
| Grade | B+ | B+ |
| Semaglutide | $129/mo | $179/mo |
| Tirzepatide | $129/mo | $239/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
| Relationship | Editorial | Editorial |
What we like
The caveats
What we like
The caveats
Our pick — visit
People who want behavior-change coaching bundled with medication.
Visit Found Read the full Found review →Our pick — visit
Anyone who wants every option on one account: compounded, brand-name or oral, without leaving to shop around.
Visit Vaylen Read the full Vaylen review →Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.